GeneDx Shares Fall After Short-Seller Grizzly Research Alleges 'Illegal Billing Practices'

MT Newswires Live

Feb 06, 2025

GeneDx Holdings (WGS) shares were down over 5% in recent Wednesday trading following a Grizzly Research report alleging that the company is inflating its revenue through illegal billing practices.

The report claims GeneDx has been using a method called "code stacking" that involves billing insurers with multiple procedure codes for the same test to secure reimbursements above standard rates.

Insiders said that CEO Katherine Stueland and CFO Kevin Feeley have consistently sold shares immediately upon vesting, suggesting they might be aware of an "imminent risk," the report said. Additional allegations from the short-seller include that the company operated "independent" counselor entities to steer patients exclusively toward its testing services.

The Department of Justice is stepping up its scrutiny of billing practices in Medicare and Medicaid, with penalties already exceeding $800 million for similar fraud cases and they expect GeneDx to be next if further evidence of wrongdoing emerges, Grizzly Research said, citing industry sources.

GeneDx did not immediately respond to a request for comment from MT Newswires.

Price: 68.22, Change: -3.80, Percent Change: -5.28

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2509369852"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509369852\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509369852?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-06 00:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509369852","market":"sg","top_or_hot":-1,"title":"GeneDx Shares Fall After Short-Seller Grizzly Research Alleges 'Illegal Billing Practices'","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/WGS\">GeneDx Holdings</a> (WGS) shares were down over 5% in recent Wednesday trading following a Grizzly Research report alleging that the company is inflating its revenue through illegal billing practices.</p><p>The report claims GeneDx has been using a method called \"code stacking\" that involves billing insurers with multiple procedure codes for the same test to secure reimbursements above standard rates.</p><p>Insiders said that CEO Katherine Stueland and CFO Kevin Feeley have consistently sold shares immediately upon vesting, suggesting they might be aware of an \"imminent risk,\" the report said. Additional allegations from the short-seller include that the company operated \"independent\" counselor entities to steer patients exclusively toward its testing services.</p><p>The Department of Justice is stepping up its scrutiny of billing practices in Medicare and Medicaid, with penalties already exceeding $800 million for similar fraud cases and they expect GeneDx to be next if further evidence of wrongdoing emerges, Grizzly Research said, citing industry sources.</p><p>GeneDx did not immediately respond to a request for comment from MT Newswires.</p><p>Price: 68.22, Change: -3.80, Percent Change: -5.28</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GeneDx Shares Fall After Short-Seller Grizzly Research Alleges 'Illegal Billing Practices'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeneDx Shares Fall After Short-Seller Grizzly Research Alleges 'Illegal Billing Practices'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-06 00:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/WGS\">GeneDx Holdings</a> (WGS) shares were down over 5% in recent Wednesday trading following a Grizzly Research report alleging that the company is inflating its revenue through illegal billing practices.</p><p>The report claims GeneDx has been using a method called \"code stacking\" that involves billing insurers with multiple procedure codes for the same test to secure reimbursements above standard rates.</p><p>Insiders said that CEO Katherine Stueland and CFO Kevin Feeley have consistently sold shares immediately upon vesting, suggesting they might be aware of an \"imminent risk,\" the report said. Additional allegations from the short-seller include that the company operated \"independent\" counselor entities to steer patients exclusively toward its testing services.</p><p>The Department of Justice is stepping up its scrutiny of billing practices in Medicare and Medicaid, with penalties already exceeding $800 million for similar fraud cases and they expect GeneDx to be next if further evidence of wrongdoing emerges, Grizzly Research said, citing industry sources.</p><p>GeneDx did not immediately respond to a request for comment from MT Newswires.</p><p>Price: 68.22, Change: -3.80, Percent Change: -5.28</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WGS","symbol_name":"GeneDx Holdings","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2509369852","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509369852","pubTimestamp":1738773168,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"GeneDx Holdings  shares were down over 5% in recent Wednesday trading following a Grizzly Research report alleging that the company is inflating its revenue through illegal billing practices.The report claims GeneDx has been using a method called \"code stacking\" that involves billing insurers with multiple procedure codes for the same test to secure reimbursements above standard rates.Insiders said that CEO Katherine Stueland and CFO Kevin Feeley have consistently sold shares immediately upon vesting, suggesting they might be aware of an \"imminent risk,\" the report said. Additional allegations from the short-seller include that the company operated \"independent\" counselor entities to steer patients exclusively toward its testing services.The Department of Justice is stepping up its scrutiny of billing practices in Medicare and Medicaid, with penalties already exceeding $800 million for similar fraud cases and they expect GeneDx to be next if further evidence of wrongdoing emerges, Griz","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WGS":"GeneDx Holdings","BK4196":"保健护理服务"},"translate_title":"卖空者Grizzly Research指控“非法计费行为”后，GeneDx股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WGS":0.9},"content_text":"GeneDx Holdings (WGS) shares were down over 5% in recent Wednesday trading following a Grizzly Research report alleging that the company is inflating its revenue through illegal billing practices.The report claims GeneDx has been using a method called \"code stacking\" that involves billing insurers with multiple procedure codes for the same test to secure reimbursements above standard rates.Insiders said that CEO Katherine Stueland and CFO Kevin Feeley have consistently sold shares immediately upon vesting, suggesting they might be aware of an \"imminent risk,\" the report said. Additional allegations from the short-seller include that the company operated \"independent\" counselor entities to steer patients exclusively toward its testing services.The Department of Justice is stepping up its scrutiny of billing practices in Medicare and Medicaid, with penalties already exceeding $800 million for similar fraud cases and they expect GeneDx to be next if further evidence of wrongdoing emerges, Grizzly Research said, citing industry sources.GeneDx did not immediately respond to a request for comment from MT Newswires.Price: 68.22, Change: -3.80, Percent Change: -5.28","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}